CN
TAILIN supports the production of Novel Coronavirus vaccine
2021-01-22
The vaccine is the most powerful weapon against the COVID-19 epidemic, and the need of vaccine for epidemic prevention is urgent. Wuhan Institute of Chinese Institute of Biological Products (owned by SINOPHARM) has started the construction of laboratory and workshop mainly for the development and production of the COVID-19 vaccine. To control the epidemic,the workshop should be built and put into use as soon as possible.
As one of the suppliers, TAILIN spared no effort to manufacture the equipments for this project and delivered them on time.
TAILIN received the Letter of Thanks from Sinopharm because of the excellent job.
Latest News
New products launch on 61th CIPM (Autumn 2021)
TAILIN fight against the COVID-19 with 1.4 billion people
Strategic cooperation with Lotus Lake BioMedical Technology
TAILIN won the 2021 CAPE Science and Technology Innovation Award
TAILIN participated in the release of two industry standards